Filing Flows › Corteva (CTVA) › R&D spending
Corteva (CTVA) R&D spending by quarter
Corteva's R&D spending was $388M in Q2 2026 (second quarter 2026), +14% from Q1 2026. Over the last 7 quarters it ranged from $335M (Q1 2025) to $413M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $388M | +14% | +3% |
| Q1 2026 | $341M | -17% | +2% |
| Q4 2025 | $413M | +18% | +13% |
| Q3 2025 | $351M | -6% | — |
| Q2 2025 | $375M | +12% | — |
| Q1 2025 | $335M | -8% | — |
| Q4 2024 | $365M | — | — |
Q2 2026 at a glance
Corteva, Q2 2026: revenue $6.4B (-1% year over year), operating margin 24.7%, net earnings $1.2B, operating cash flow −$466M. The chart follows the revenue to costs, profit and cash.
Questions
What is Corteva's R&D spending?
Corteva's R&D spending was $388M in Q2 2026 (second quarter 2026), +14% from Q1 2026.
How has Corteva's R&D spending changed?
Over the last 7 quarters it ranged from $335M (Q1 2025) to $413M (Q4 2025).